NASP expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.07123207474069E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.7559999837834E-09 |
Normal-vs-Stage2 |
1.195930E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.749600E-02 |
Stage1-vs-Stage2 |
2.220800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.872440E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.750000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.93589621900037E-11 |
Normal-vs-AfricanAmerican |
1.536590E-01 |
Normal-vs-Asian |
2.204400E-02 |
Caucasian-vs-AfricanAmerican |
1.265000E-01 |
Caucasian-vs-Asian |
9.630600E-01 |
AfricanAmerican-vs-Asian |
1.678800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.48150000001124E-06 |
Normal-vs-Female |
8.78489999633913E-08 |
Male-vs-Female |
8.719000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.232800E-04 |
Normal-vs-Extreme_Weight |
1.34890000003107E-06 |
Normal-vs-Obese |
3.240700E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.222200E-02 |
Normal_Weight-vs-Obese |
3.781700E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.381400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.285800E-01 |
Normal-vs-Age(41-60Yrs) |
3.625000E-04 |
Normal-vs-Age(61-80Yrs) |
1.06529995935745E-09 |
Normal-vs-Age(81-100Yrs) |
4.130400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.419000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.770600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.487400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.610200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.074600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.855400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.401000E-01 |
Normal-vs-Grade 3 |
5.716200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.774600E-01 |
Grade 2-vs-Grade 4 |
5.401000E-01 |
Grade 3-vs-Grade 4 |
5.716200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.34479982705216E-10 |
Normal-vs-N1 |
3.196200E-02 |
N0-vs-N1 |
3.206400E-01 |
|
|